Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review

Journal of Clinical Immunology

Volumn 37, Issue 2, 2017, Pages 166-179

  Wu, Jing ^a   Chen, Ji ^a   Tian, Zhi Qing ^a   Zhang, Hao ^a   Gong, Ruo Lan ^a   Chen, Tong Xin ^a   Hong, Li ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Autosomal dominant; Chinese; hyper IgE syndrome; infections; noninfection symptoms; STAT3 mutations

Indexed keywords

ALLERGEN; BCG VACCINE; CD27 ANTIGEN; GENOMIC DNA; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN M; MILK PROTEIN; STAT3 PROTEIN;

ABSCESS DRAINAGE; ADOLESCENT; ADULT; ANKLE FRACTURE; ARTICLE; ASPERGILLUS; ATELECTASIS; AUTOSOMAL DOMINANT DISORDER; BCG VACCINATION; BRONCHIECTASIS; CHILD; CHINA; CHRONIC OTITIS MEDIA; CLAVICLE FRACTURE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINODACTYLY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DECIDUOUS TOOTH; DISEASE SEVERITY; DNA SEQUENCE; ECZEMA; EGG; EOSINOPHIL COUNT; EPSTEIN BARR VIRUS INFECTION; EXCISION; EXON; FACIES; FEMALE; FEMORAL HEAD FRACTURE; FEMUR FRACTURE; FIBULA FRACTURE; FOLLICULITIS; FOOD ALLERGY; FOOT FRACTURE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; HEPATOMEGALY; HIP DISLOCATION; HUMAN; HYPER IGE SYNDROME; INCISION; INFECTION CONTROL; INJECTION SITE ABSCESS; INJECTION SITE ULCER; LIVER ABSCESS; LIVER RESECTION; LOWER RESPIRATORY TRACT INFECTION; LUNG LOBECTOMY; LYMPH NODE ABSCESS; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY CELL; MULTIPLE FRACTURE; MYCOPLASMA PNEUMONIA; NONHUMAN; ONSET AGE; ONYCHOMYCOSIS; PEANUT; PLEURA THICKENING; PNEUMATOCELE; PNEUMONIA; PNEUMOTHORAX; PRESCHOOL CHILD; PRICK TEST; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PUSTULOSIS; RECURRENT INFECTION; RETROSPECTIVE STUDY; SCHOOL CHILD; SCOLIOSIS; SCORAD INDEX; SEA FOOD; SEPSIS; SHOULDER DISLOCATION; SKELETON MALFORMATION; SKIN ABSCESS; SKIN DISEASE ASSESSMENT; SKIN INFECTION; SOY FOOD; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; STAT3 DEFICIENCY; STREPTOCOCCUS; STREPTOCOCCUS CONSTELLATUS; THRUSH; TIBIA FRACTURE; TRICUSPID VALVE REGURGITATION; ULNA FRACTURE; UPPER RESPIRATORY TRACT INFECTION; YOUNG ADULT; BLOOD; CASE REPORT; COMPLICATION; EOSINOPHIL; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MUTATION; PHENOTYPE; SYMPTOM ASSESSMENT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHINA; EOSINOPHILS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULIN E; IMMUNOPHENOTYPING; JOB SYNDROME; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MUTATION; PHENOTYPE; STAT3 TRANSCRIPTION FACTOR; SYMPTOM ASSESSMENT; YOUNG ADULT;

EID: 85012922263     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-017-0369-7     Document Type: Article

References (46)

1. Davis SD, Schaller J, Wedgwood RJ. Job’s syndrome. Recurrent, “cold”, staphylococcal abscesses. Lancet. 1966;1(7445):1013–5.
2. Buckley RH, Wray BB, Belmaker EZ. Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics. 1972;49(1):59–70.
3. Rezaei N, Aghamohammadi A. Hyper-IgE syndrome. J Postgrad Med. 2010;56(2):63–4. doi:10.4103/0022-3859.65271.
4. Minegishi Y, Karasuyama H. Genetic origins of hyper-IgE syndrome. Curr Allergy Asthma Rep. 2008;8(5):386–91.
5. Wu G, Hitchen PG, Panico M, North SJ, Barbouche MR, Binet D, et al. Glycoproteomic studies of IgE from a novel hyper IgE syndrome linked to PGM3 mutation. Glycoconj J. 2016;33(3):447–56. doi:10.1007/s10719-015-9638-y.
6. Qin T, An Y, Liu C, Wu J, Dai R, Liu D, et al. Novel DOCK8 gene mutations lead to absence of protein expression in patients with hyper-IgE syndrome. Immunol Res. 2016;64(1):260–71. doi:10.1007/s12026-015-8745-y.
7. Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357(16):1608–19. doi:10.1056/NEJMoa073687.
8. Mogensen TH. STAT3 and the hyper-IgE syndrome: clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties. Jak-Stat. 2013;2(2):e23435. doi:10.4161/jkst.23435.
9. Sowerwine KJ, Holland SM, Freeman AF. Hyper-IgE syndrome update. Ann N Y Acad Sci. 2012;1250:25–32. doi:10.1111/j.1749-6632.2011.06387.x.
10. Minegishi Y. Hyper-IgE syndrome. Curr Opin Immunol. 2009;21(5):487–92. doi:10.1016/j.coi.2009.07.013.
11. Ives ML, Ma CS, Palendira U, Chan A, Bustamante J, Boisson-Dupuis S, et al. Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function. J Allergy Clin Immunol. 2013;132(2):400–11 e9.
12. Kane A, Deenick EK, Ma CS, Cook MC, Uzel G, Tangye SG. STAT3 is a central regulator of lymphocyte differentiation and function. Curr Opin Immunol. 2014;28:49–57. doi:10.1016/j.coi.2014.01.015.
13. Linnekin D, Mou S, Deberry CS, Weiler SR, Keller JR, Ruscetti FW, et al. Stem cell factor, the JAK-STAT pathway and signal transduction. Leuk Lymphoma. 1997;27(5–6):439–44. doi:10.3109/10428199709058310.
14. Weber-Nordt RM, Mertelsmann R, Finke J. The JAK-STAT pathway: signal transduction involved in proliferation, differentiation and transformation. Leuk Lymphoma. 1998;28(5–6):459–67. doi:10.3109/10428199809058353.
15. Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, Grimbacher B, et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med. 2008;205(7):1551–7. doi:10.1084/jem.20080218.
16. Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 2008;452(7188):773–6. doi:10.1038/nature06764.
17. Sharma S, Saikia B, Goel S, Rawat A, Minz RW, Suri D, et al. TH17 cells in STAT3 related hyper-IgE syndrome. Indian J Pediatr. 2016. doi:10.1007/s12098-016-2150-y.
18. Speckmann C, Enders A, Woellner C, Thiel D, Rensing-Ehl A, Schlesier M, et al. Reduced memory B cells in patients with hyper IgE syndrome. Clin Immunol. 2008;129(3):448–54. doi:10.1016/j.clim.2008.08.002.
19. Levy DE, Darnell Jr JE. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002;3(9):651–62. doi:10.1038/nrm909.
20. Murray PJ. The JAK-STAT signaling pathway: input and output integration. J Immunol. 2007;178(5):2623–9.
21. O’Shea JJ, Murray PJ. Cytokine signaling modules in inflammatory responses. Immunity. 2008;28(4):477–87. doi:10.1016/j.immuni.2008.03.002.
22. Woellner C, Gertz EM, Schaffer AA, Lagos M, Perro M, Glocker EO, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol. 2010;125(2):424–32 e8.
23. Jiao H, Toth B, Erdos M, Fransson I, Rakoczi E, Balogh I, et al. Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups. Mol Immunol. 2008;46(1):202–6. doi:10.1016/j.molimm.2008.07.001.
24. Chandesris MO, Melki I, Natividad A, Puel A, Fieschi C, Yun L, et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine. 2012;91(4):e1–19. doi:10.1097/MD.0b013e31825f95b9.
25. Xie L, Hu X, Li Y, Zhang W, Chen L. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China. Clin Dev Immunol. 2010;2010:289873.
26. Zeng H, Tao Y, Chen X, Zeng P, Wang B, Wei R, et al. Primary immunodeficiency in South China: clinical features and a genetic subanalysis of 138 children. J Investig Allergology Clin Immunol. 2013;23(5):302–8.
27. Liu JY, Li Q, Chen TT, Guo X, Ge J, Yuan LX. Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S). Eur J Pediatr. 2011;170(5):661–6. doi:10.1007/s00431-010-1349-6.
28. Zhang LY, Tian W, Shu L, Jiang LP, Zhan YZ, Liu W, et al. Clinical features, STAT3 gene mutations and Th17 cell analysis in nine children with hyper-IgE syndrome in mainland China. Scand J Immunol. 2013;78(3):258–65. doi:10.1111/sji.12063.
29. Li ZT, Wang S, Wang X. Mutation analysis of the STAT3 gene in a patient with hyper-IgE syndrome. Chin J Dermatol. 2015;48:735–7.
30. Liu JR, Duan XM, Guo AX, Zhao SY, Jiang ZF. A case report of hyper IgE syndrome combined with pulmonary arterial disorders. Chin J Pediatr. 2013;51:692–3.
31. Xue L, Zhang M, Yang Y, Wang S. Mutation analysis of the STAT3 gene in a patient with hyper-IgE syndrome. Chin J Dermatol. 2013;46:716–8.
32. Zhang GQ, Cao L, Zhu CM, Wang YJ. STAT3 gene mutation associated with hyper-immunoglobulin E syndrome: a case study and the review of the related literature. Chin J Appl Clin Pediatr. 2016;31:309–11.
33. Lee WI, Huang JL, Lin SJ, Yeh KW, Chen LC, Ou LS, et al. Clinical, immunological and genetic features in Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES). Immunobiology. 2011;216(8):909–17. doi:10.1016/j.imbio.2011.01.008.
34. Group CTFPs. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010;135(2):264–72. doi:10.1016/j.clim.2010.02.021.
35. Ishimura M, Takada H, Doi T, Imai K, Sasahara Y, Kanegane H, et al. Nationwide survey of patients with primary immunodeficiency diseases in Japan. J Clin Immunol. 2011;31(6):968–76. doi:10.1007/s10875-011-9594-7.
36. Lee WI, Huang JL, Jaing TH, Shyur SD, Yang KD, Chien YH, et al. Distribution, clinical features and treatment in Taiwanese patients with symptomatic primary immunodeficiency diseases (PIDs) in a nationwide population-based study during 1985–2010. Immunobiology. 2011;216(12):1286–94. doi:10.1016/j.imbio.2011.06.002.
37. Ma H, Kuang L, Lv G, Wang B, Lian Z. Vertebral aspergillosis in a patient with autosomal-dominant hyper-IgE syndrome. Clin Vaccine Immunol: CVI. 2014;21(1):107–9. doi:10.1128/CVI.00529-13.
38. Zhong H, Song Z, Wang H, Zhang W, Hao F. A child case of hyper-IgE syndrome. Allergy. 2010;65(12):1622–3.
39. Renner ED, Rylaarsdam S, Anover-Sombke S, Rack AL, Reichenbach J, Carey JC, et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol. 2008;122(1):181–7. doi:10.1016/j.jaci.2008.04.037.
40. Jinnestal CL, Belfrage E, Back O, Schmidtchen A, Sonesson A. Skin barrier impairment correlates with cutaneous Staphylococcus aureus colonization and sensitization to skin-associated microbial antigens in adult patients with atopic dermatitis. Int J Dermatol. 2014;53(1):27–33. doi:10.1111/ijd.12198.
41. Baker BS. The role of microorganisms in atopic dermatitis. Clin Exp Immunol. 2006;144(1):1–9. doi:10.1111/j.1365-2249.2005.02980.x.
42. Garty BZ, Ben-Baruch A, Rolinsky A, Woellner C, Grimbacher B, Marcus N. Pneumocystis jirovecii pneumonia in a baby with hyper-IgE syndrome. Eur J Pediatr. 2010;169(1):35–7. doi:10.1007/s00431-009-0973-5.
43. Esposito L, Poletti L, Maspero C, Porro A, Pietrogrande MC, Pavesi P, et al. Hyper-IgE syndrome: dental implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(2):147–53.
44. Chandesris MO, Azarine A, Ong KT, et al. Frequent and widespread vascular abnormalities in human STAT3 deficiency. Artery Res. 2011;5(4):163.
45. Dang Y, Ren J, Guo Y, Geng S. Hyper IgE syndrome. Indian Dermatol Online J. 2014;5(1):69–71.
46. Vogel TP, Milner JD, Cooper MA. The Ying and Yang of STAT3 in human disease. J Clin Immunol. 2015;35(7):615–23. doi:10.1007/s10875-015-0187-8.